Separate names with a comma.
U.S. and Switzerland working on facilitating pharma trade...
MindMed Strengthens Board with Appointment of Two New Independent Directors NEWS PROVIDED BY Mind Medicine (MindMed) Inc. Aug 12, 2022, 07:30...
MindMed Reports Second Quarter 2022 Financial Results and Business Highlights NEWS PROVIDED BY Mind Medicine (MindMed) Inc. Aug 11, 2022,...
MindMed Board of Directors Approves Reverse Share Split NEWS PROVIDED BY Mind Medicine (MindMed) Inc. Aug 04, 2022, 17:30 ET SHARE THIS...
Just as a note -We don't want FCM invovled.
FCM MM HOLDINGS, LLC Letter to MNMD August 11, 2022 Carol Vallone Chairman of the Board of Directors Mind Medicine (MindMed) Inc. One World Trade...
MindMed Co-Founder Dr. Scott Freeman Proposes Value Enhancement Plan...
Michael Pollan on How Psychedelics Will Play a Bigger Role in American Life ‘There will be a medical industry providing psychedelic therapy,’ the...
Sector will wake up soon. Public awareness is spreading.
VIDEO - Michael Pollan: Psilocybin And MDMA Will Be Legal Therapeutic Drugs Within Five Years [MEDIA]
MindMed - Corporate Deck - July 2022 Download and Read Here:...
MindMed Promo Video (new) 7-20-22 https://mindmed.co/wp-content/themes/mindmed/video/home-video.mp4
Trailer to show: [MEDIA]
Episode 1 of Michael Pollan's "How to Change Your Mind" (available on Netflix) highlights the groundbreaking research being done by MindMed's...
Biotech Sector Stock Picks: MNMD [MEDIA]
How to Change Your Mind Medical TV Shows Author Michael Pollan leads the way in this docuseries exploring the history and uses of psychedelics,...
Stevia Corp. Announces Appointment of the Former Chief Science Officer for Quest Diagnostics to its Scientific Advisory Panel June 14, 2022, 4:00...
Stevia Corp. Publishes Shareholder Letter Dated June 3, 2022 Press Release | 06/03/2022 Letter Highlights New Business Initiatives with First...
Looks like the company sent out a tweet last week that a shareholder update is coming soon....
MindMed believes its available cash will be sufficient to meet its operating requirements beyond its key development milestones in 2023 and into 2024.
